Cocrystal Pharma
Dr. Phillip Frost is the Chairman and CEO of OPKO Health, Inc. (NYSE: OPK). Dr. Frost is the former Chairman of the Board of Teva Pharmaceuticals (NYSE: TEVA). Dr. Frost served as Chairman and CEO of IVAX Corporation from 1987 through that firm’s acquisition by IVAX Corporation in January 2006. He has served on the Board of Regents of the Smithsonian Institution, on the Board of Trustees of the University of Miami, as a Trustee of each of the Scripps Research Institutes, and is a director of numerous other organizations.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Cocrystal Pharma
Cocrystal Pharma, Inc., formerly Biozone Pharmaceuticals, Inc., is engaged in developing medicines for use in the treatment of human viral diseases. The Company develops technologies and approaches to create antiviral drug candidates. The Company is de...